Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

PSTX Poseida Therapeutics Inc

2,64

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:00:08

Verzögert um 15 Minuten

Biotech Soars on Research Collaboration And License Agreement Release

A California-based biotech company is turning heads on Wednesday after it announced that it entered into a research collaboration and license agreement with Astellas...

To read the full story on AllPennyStocks.com, click here.

Poseida Therapeutics (NASDAQ:PSTX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Poseida Therapeutics Charts.

Poseida Therapeutics (NASDAQ:PSTX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Poseida Therapeutics Charts.

News Poseida Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 18 Juni 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 18 Juni 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 18 Juni 2024 (2 Tage vor) • Edgar (US Regulatory)

Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders
Montag 3 Juni 2024 (2 Wochen vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Dienstag 14 Mai 2024 (1 Monat vor) • PR Newswire (US)

Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting
Donnerstag 9 Mai 2024 (1 Monat vor) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Montag 6 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Donnerstag 2 Mai 2024 (2 Monate vor) • PR Newswire (US)

Biotech Soars on Research Collaboration And License Agreement Release
Mittwoch 1 Mai 2024 (2 Monate vor) • AllPennyStocks.com

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Mittwoch 1 Mai 2024 (2 Monate vor) • PR Newswire (US)

Weitere Poseida Therapeutics Inc News-Artikel

NLBNPIT1Y1A1 20991231 43...

BNP Paribas Issuance

Oatei Tf 0,1% Mz29 Eur

Picton Mahoney Tactical ...

American Telecom

CI Morningstar National ...

Austria Green Tf 2,9% Mg...

Becton Dickinson &

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen